Published in J Clin Immunol on December 16, 2011
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell (2007) 4.85
[Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris) (1968) 4.44
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol (2009) 3.22
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Introduction to galectins. Glycoconj J (2004) 2.30
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest (2008) 2.15
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12
The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem (1998) 2.10
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci (2010) 1.83
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol (2008) 1.76
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol (1995) 1.66
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol (2008) 1.64
Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci (2000) 1.47
Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int (2004) 1.46
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet (2006) 1.41
The role of galectins in protein trafficking. Traffic (2009) 1.37
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol (2007) 1.36
Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol (2001) 1.34
Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem (2001) 1.34
Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology (2007) 1.21
Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J (2004) 1.11
Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology (2008) 1.07
Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med (2005) 1.04
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry (2010) 1.02
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int (2005) 1.01
Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans. J Biol Chem (2011) 1.00
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp Cell Res (2009) 1.00
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int (2006) 0.99
Autoimmune kidney diseases. Autoimmun Rev (2009) 0.98
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) (2007) 0.98
Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp Cell Res (2006) 0.97
The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol (2007) 0.96
Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol (2006) 0.94
The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis (2011) 0.94
Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells. J Biochem (2007) 0.93
Human platelets express and are activated by galectin-8. Biochem J (2010) 0.93
O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol (2009) 0.90
Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PLoS One (2011) 0.89
Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology (2007) 0.88
Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. J Biol Chem (2005) 0.87
Interaction between variants of two glycosyltransferase genes in IgA nephropathy. Kidney Int (2009) 0.86
Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis. Lupus (2009) 0.86
Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J Immunol (2011) 0.85
Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains. Nephron (2001) 0.81
Immunohistochemical detection of galectin-1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies. Histopathology (2007) 0.77
Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol (2004) 0.77
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med (2010) 8.64
Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis (2006) 3.68
A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics (2011) 3.37
Comparative functional analysis of the Caenorhabditis elegans and Drosophila melanogaster proteomes. PLoS Biol (2009) 3.09
Arab nations lagging behind other Middle Eastern countries in biomedical research: a comparative study. BMC Med Res Methodol (2009) 2.75
Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell (2007) 2.57
Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med (2012) 2.30
Regulation of alternative macrophage activation by galectin-3. J Immunol (2008) 2.28
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med (2011) 2.09
Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem (2008) 2.02
[In Process Citation]. Lakartidningen (2015) 2.01
The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract (2003) 1.91
Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol (2009) 1.79
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int (2010) 1.78
Visibility of Arab countries in the world biomedical literature. Libyan J Med (2011) 1.69
Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol (2008) 1.51
Rtt101 and Mms1 in budding yeast form a CUL4(DDB1)-like ubiquitin ligase that promotes replication through damaged DNA. EMBO Rep (2008) 1.51
Absolute quantification of microbial proteomes at different states by directed mass spectrometry. Mol Syst Biol (2011) 1.46
Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol (2004) 1.46
Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46
Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic (2007) 1.45
Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol (2009) 1.45
Galectin-4 in normal tissues and cancer. Glycoconj J (2004) 1.42
EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis (2010) 1.38
Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol (2007) 1.34
Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum (2013) 1.28
Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3. J Am Chem Soc (2010) 1.24
IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol (2010) 1.24
Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology (2007) 1.21
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. J Biol Chem (2006) 1.20
Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology (2005) 1.18
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) (2009) 1.18
Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction. J Am Chem Soc (2005) 1.17
Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem (2006) 1.15
Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin Cancer Res (2003) 1.15
Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology (2012) 1.12
Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol (2007) 1.11
Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. J Am Soc Nephrol (2005) 1.10
Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat Commun (2012) 1.09
50% failure rate in final year medical exams; Whose fault is it? Libyan J Med (2007) 1.09
Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes. Ann Rheum Dis (2007) 1.07
Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology (2008) 1.07
Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J Leukoc Biol (2006) 1.07
Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med (2004) 1.05
Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? Mediators Inflamm (2004) 1.05
The Libyan doctors' brain drain: an exploratory study. BMC Res Notes (2009) 1.05
Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol (2008) 1.05
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett (2010) 1.04
Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology (2008) 1.04
Medical education in Libya: the challenges. Med Teach (2009) 1.03
Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. J Immunol (2002) 1.03
Proteins of novel lactic acid bacteria from Apis mellifera mellifera: an insight into the production of known extra-cellular proteins during microbial stress. BMC Microbiol (2013) 1.01
Conformational differences in liganded and unliganded states of Galectin-3. Biochemistry (2003) 1.01
Mutational tuning of galectin-3 specificity and biological function. J Biol Chem (2010) 1.01
Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant (2010) 1.00
Ligand induced galectin-3 protein self-association. J Biol Chem (2012) 1.00
Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res (2012) 1.00
The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology (2002) 1.00
Thirty-five years of hemodialysis: two case reports as a tribute to Nils Alwall. Am J Kidney Dis (2007) 0.99
Automated selected reaction monitoring software for accurate label-free protein quantification. J Proteome Res (2012) 0.99
Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant (2009) 0.99
Autoimmune kidney diseases. Autoimmun Rev (2009) 0.98
Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected. Cell Microbiol (2002) 0.98
Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types. Biochim Biophys Acta (2012) 0.96
Data processing methods and quality control strategies for label-free LC-MS protein quantification. Biochim Biophys Acta (2013) 0.95
The carbohydrate-binding site in galectin-3 is preorganized to recognize a sugarlike framework of oxygens: ultra-high-resolution structures and water dynamics. Biochemistry (2011) 0.94
C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions. Angew Chem Int Ed Engl (2005) 0.94
Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrol Dial Transplant (2006) 0.94
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res (2009) 0.93
Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy. J Biol Chem (2008) 0.93
Electron beam-melted, free-form-fabricated titanium alloy implants: Material surface characterization and early bone response in rabbits. J Biomed Mater Res B Appl Biomater (2009) 0.93
Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis. PLoS One (2012) 0.93
2DDB - a bioinformatics solution for analysis of quantitative proteomics data. BMC Bioinformatics (2006) 0.93
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin. J Immunol (2009) 0.91
Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. Eur J Biochem (2002) 0.90
Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol (2007) 0.90
Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides. Chemistry (2008) 0.90
Taloside inhibitors of galectin-1 and galectin-3. Chem Biol Drug Des (2012) 0.90
Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PLoS One (2011) 0.89
Monovalent interactions of galectin-1. Biochemistry (2010) 0.89
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm (2009) 0.89
Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology (2007) 0.88
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3. Bioorg Med Chem Lett (2005) 0.88
Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cell Microbiol (2011) 0.88
Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal Biochem (2004) 0.88
Low micromolar inhibitors of galectin-3 based on 3'-derivatization of N-acetyllactosamine. Chembiochem (2002) 0.88
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility. BMC Nephrol (2013) 0.88
Glycosphingolipid composition of epithelial cells isolated along the villus axis of small intestine of a single human individual. Glycobiology (2012) 0.88
The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology (2008) 0.88
Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors. Carbohydr Res (2007) 0.88
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors. Bioorg Med Chem (2010) 0.87
Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden. Rheumatology (Oxford) (2012) 0.87
Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj J (2007) 0.87